Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Cynthia Gagnon
Research Interests
Explore related searches
Articles (18)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2023
Introduction/Aims Muscle weakness, and its association with mobility limitations, has received little study in oculopharyngeal muscular dystrophy (OPMD) using quantitative and standardized assessments. The objectives of this study were to (1) document upper and lower limb muscle strength, upper limb functions, fatigue, and mobility capacities; (2) compare them with reference values and across participant age groups; and (3) explore associations between muscle strength, fatigue, and mobility capacities among adults with OPMD. Methods Thirty‐four participants were included in this cross‐sectional study. The following variables were assessed: quantitative maximal isometric muscle strength, grip and pinch strength, fatigue, walking speed, walking endurance, sit‐to‐stand, and stair ascent and descent capacities. Results Muscle strength was lower for older than younger participants for five muscle groups ( P < .05). Walking endurance, sit‐to‐stand, stairs (ascent and descent), and strength of hip flexion, grip, and pinch were below 80% of reference values in participants ≥56 y old (55.3%–78.2%). Moderate to strong correlations were found between muscle strength and mobility capacities (ρ = 0.42–0.80, P < .05), and between fatigue and either muscle strength or mobility capacities (ρ = 0.42–0.75, P < .05). Discussion This study highlights the impact of OPMD on strength, endurance, and functional capacity, among others, with patients being well below reference values even before the age of 65 y. In addition to helping health professionals to offer better clinical guidance, these results will improve clinical trial readiness. The next steps will be to assess the metrological properties of outcome measures and continue to document the disease progression rate.
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Collaborators (12)
Krista L. Best
Associate Professor
Laval University
P.A. Boelen
Utrecht University
Kévin Bouchard
Université du Québec à Chicoutimi
Lola E. R Lessard
Adult neurologist (Assistant Chef de Clinique)
Hospices Civils de Lyon
Luc Laberge
Professeur associé
Université de Sherbrooke
Benjamin Gallais
Professeur associé
Université de Sherbrooke
Claudia Côté
Laval University
Sirio Cocozza
-
Jean-philippe Leduc-Gaudet
Professor
Université du Québec à Trois-Rivières
Matthis Synofzik
Professor
Hertie Institute for clinical brain research
Elise Duchesne
Professeure agrégée
Université du Québec à Chicoutimi
Hanns Lochmüller
Senior Scientist
-
Make your next move.
Prepare your application
Review drafts before you send them.